Understanding Lymphoma from a Lab Perspective
In this presentation we summarize the pathologic classification of Lymphomas according to the 2008 WHO classification. We focus on the aspect for the classification that is related to laboratory such as workflow and ancillary testing including flow cytometry utilized in the diagnosis. We compare and contrast the natural history, clinical features, staging and treatment approach of common NHL subtypes as well as the relevant therapeutic implications for reaching to correct diagnosis.
Originally presented on May 26, 2015 in Salt Lake City, Utah.
Mohamed E. Salama, MD
Medical Director, Hematopathology and Immunoperoxidase Staining, ARUP Laboratories
Director, Hematopathology Fellowship Program, University of Utah School of Medicine
Associate Professor of Pathology, University of Utah School of Medicine
Dr. Salama is an associate professor of pathology and director of the hematopathology fellowship program at the University of Utah School of Medicine. Dr. Salama received his MD from Cairo University and completed a hematopathology fellowship at the University of New Mexico and a surgical pathology fellowship at Stanford University. He is certified by the American Board of Pathology in anatomic pathology and hematopathology. His areas of interest span all aspects of hematopathology, including morphology and specialized studies of bone marrow and lymph node.
After this presentation, participants will be able to:
- Describe the pathogenesis of NHL
- Summarize the pathologic classification of Lymphoms (the 2008 WHO classification).
- Compare and contrast the natural history, clinical features, staging and treatment approach of common NHL subtypes.
- Describe the clinical features associated with Hodgkin lymphoma and pathologic findings required to render this diagnosis.